Ezio Bonvini

Person

Potomac, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
HER2/neu-specific antibodies and methods of using same
- Patent number 12,024,569
- Issue date Jul 2, 2024
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding molecules that are capable of binding CD137 and...
- Patent number 11,942,149
- Issue date Mar 26, 2024
- MacroGenics, Inc.
- Liqin Liu
- G11 - INFORMATION STORAGE
Information Patent Grant
LAG-3-binding molecules and methods of use thereof
- Patent number 11,858,991
- Issue date Jan 2, 2024
- MacroGenics, Inc.
- Ross La Motte-Mohs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using bispecific molecules having immunoreactivity with...
- Patent number 11,840,571
- Issue date Dec 12, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-chain polypeptide-containing tri-specific binding molecules
- Patent number 11,820,818
- Issue date Nov 21, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tri-specific binding molecules that specifically bind to multiple c...
- Patent number 11,697,684
- Issue date Jul 11, 2023
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variant CD3-binding domains and their use in combination therapies...
- Patent number 11,685,781
- Issue date Jun 27, 2023
- Ezio Bonvini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding CD19 a...
- Patent number 11,639,386
- Issue date May 2, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-1-binding molecules and methods of use thereof
- Patent number 11,623,959
- Issue date Apr 11, 2023
- MacroGenics, Inc.
- Kalpana Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
B7-H3 directed antibody drug conjugates
- Patent number 11,591,400
- Issue date Feb 28, 2023
- MacroGenics, Inc.
- Deryk T. Loo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding molecules that are capable of binding CD137 and...
- Patent number 11,459,394
- Issue date Oct 4, 2022
- MacroGenics, Inc.
- Liqin Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bi-specific monovalent Fc diabodies that are capable of binding CD3...
- Patent number 11,384,149
- Issue date Jul 12, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ADAM9-binding molecules, and methods of use thereof
- Patent number 11,242,402
- Issue date Feb 8, 2022
- MacroGenics, Inc.
- Deryk T. Loo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy for the treatment of cancer
- Patent number 11,174,315
- Issue date Nov 16, 2021
- MacroGenics, Inc.
- James Vasselli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalently bonded diabodies having immunoreactivity with PD-1 and L...
- Patent number 11,098,119
- Issue date Aug 24, 2021
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy for the treatment of cancer
- Patent number 11,078,279
- Issue date Aug 3, 2021
- MacroGenics, Inc.
- Jon Marc Wigginton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LAG-3-binding molecules and methods of use thereof
- Patent number 11,072,653
- Issue date Jul 27, 2021
- MacroGenics, Inc.
- Ross La Motte-Mohs
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HER2/neu-specific antibodies and methods of using same
- Patent number 11,028,183
- Issue date Jun 8, 2021
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
B7-H3 binding molecules, antibody drug conjugates thereof and metho...
- Patent number 10,961,311
- Issue date Mar 30, 2021
- MacroGenics, Inc.
- Deryk T. Loo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific molecules having immunoreactivity with PD-1 and CTLA-4,...
- Patent number 10,954,301
- Issue date Mar 23, 2021
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding to gpA...
- Patent number 10,858,430
- Issue date Dec 8, 2020
- MacroGenics, Inc.
- Paul A. Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding CD123...
- Patent number 10,787,521
- Issue date Sep 29, 2020
- MacroGenics, Inc.
- Ezio Bonvini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-chain polypeptide-containing tri-specific binding molecules
- Patent number 10,647,768
- Issue date May 12, 2020
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-chain polypeptide-containing tri-specific binding molecules t...
- Patent number 10,633,440
- Issue date Apr 28, 2020
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding CD19 a...
- Patent number 10,633,443
- Issue date Apr 28, 2020
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-1-binding molecules and methods of use thereof
- Patent number 10,577,422
- Issue date Mar 3, 2020
- MacroGenics, Inc.
- Kalpana Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bi-specific monovalent Fc diabodies that are capable of binding CD3...
- Patent number 10,344,092
- Issue date Jul 9, 2019
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalently bonded diabodies having immunoreactivity with PD-1 and L...
- Patent number 10,160,806
- Issue date Dec 25, 2018
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HER2/neu-specific antibodies and methods of using same
- Patent number 10,131,713
- Issue date Nov 20, 2018
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding to gpA...
- Patent number 9,932,400
- Issue date Apr 3, 2018
- MacroGenics, Inc.
- Paul A. Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND...
- Publication number 20240233818
- Publication date Jul 11, 2024
- MacroGenics, Inc.
- Liqin LIU
- G11 - INFORMATION STORAGE
Information Patent Application
MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES T...
- Publication number 20240182559
- Publication date Jun 6, 2024
- MacroGenics, Inc.
- Leslie S. JOHNSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LAG-3-Binding Molecules and Methods of Use Thereof
- Publication number 20240124582
- Publication date Apr 18, 2024
- MacroGenics, Inc.
- Ross La Motte-Mohs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE C...
- Publication number 20240117036
- Publication date Apr 11, 2024
- MacroGenics, Inc.
- Ezio BONVINI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...
- Publication number 20240084015
- Publication date Mar 14, 2024
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Variant CD3-Binding Domains and Their Use in Combination Therapies...
- Publication number 20240043537
- Publication date Feb 8, 2024
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 a...
- Publication number 20230399399
- Publication date Dec 14, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20230357404
- Publication date Nov 9, 2023
- MacroGenics, Inc.
- Kalpana Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE USE OF A PD-1 X CTLA-4 BISPECIFIC MOLECULE
- Publication number 20230312756
- Publication date Oct 5, 2023
- MacroGenics, Inc.
- Bradley James SUMROW
- C07 - ORGANIC CHEMISTRY
Information Patent Application
B7-H3 DIRECTED ANTIBODY DRUG CONJUGATES
- Publication number 20230272084
- Publication date Aug 31, 2023
- MacroGenics, Inc.
- Deryk T. LOO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 BINDING MOLECULES AND USES THEREOF
- Publication number 20230094162
- Publication date Mar 30, 2023
- MacroGenics, Inc.
- Alexey Yevgenyevich BEREZHNOY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapy for the Treatment of Cancer
- Publication number 20230056230
- Publication date Feb 23, 2023
- MacroGenics, Inc.
- Bradley James Sumrow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND...
- Publication number 20220406376
- Publication date Dec 22, 2022
- MacroGenics, Inc.
- Liqin LIU
- G11 - INFORMATION STORAGE
Information Patent Application
Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD3...
- Publication number 20220372144
- Publication date Nov 24, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADAM9-Binding Molecules, and Methods of Use Thereof
- Publication number 20220324995
- Publication date Oct 13, 2022
- MacroGenics, Inc.
- Deryk T. Loo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy for the Treatment of Cancer
- Publication number 20220204625
- Publication date Jun 30, 2022
- MacroGenics, Inc.
- James Vasselli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HER2/neu-Specific Antibodies and Methods of Using Same
- Publication number 20220089773
- Publication date Mar 24, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapy for the Treatment of Cancer
- Publication number 20220041725
- Publication date Feb 10, 2022
- MacroGenics, Inc.
- Jon Marc Wigginton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and L...
- Publication number 20220041714
- Publication date Feb 10, 2022
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF
- Publication number 20210388102
- Publication date Dec 16, 2021
- ImmunoGen, Inc.
- Stuart William Hicks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF
- Publication number 20210275685
- Publication date Sep 9, 2021
- ImmunoGen, Inc.
- Stuart William Hicks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LAG-3-Binding Molecules and Methods of Use Thereof
- Publication number 20210206851
- Publication date Jul 8, 2021
- MacroGenics, Inc.
- Ross La Motte-Mohs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL B7-H3 BINDING MOLECULES, ANTIBODY DRUG CONJUGATES THEREOF AND...
- Publication number 20210171641
- Publication date Jun 10, 2021
- MacroGenics, Inc.
- Deryk T. LOO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Variant CD3-Binding Domains and Their Use in Combination Therapies...
- Publication number 20210155694
- Publication date May 27, 2021
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...
- Publication number 20210130470
- Publication date May 6, 2021
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bi-Specific Monovalent Diabodies That are Capable of Binding CD123...
- Publication number 20210047426
- Publication date Feb 18, 2021
- MacroGenics, Inc.
- Ezio Bonvini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY
- Publication number 20200255524
- Publication date Aug 13, 2020
- MacroGenics, Inc.
- Ezio Bonvini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20200231675
- Publication date Jul 23, 2020
- MacroGenics, Inc.
- Kalpana Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 a...
- Publication number 20200216537
- Publication date Jul 9, 2020
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES T...
- Publication number 20200207850
- Publication date Jul 2, 2020
- MacroGenics, Inc.
- Leslie S. JOHNSON
- C07 - ORGANIC CHEMISTRY

Ezio Bonvini

Person

Patents Grantslast 30 patents

HER2/neu-specific antibodies and methods of using same

Bispecific binding molecules that are capable of binding CD137 and...

LAG-3-binding molecules and methods of use thereof

Methods of using bispecific molecules having immunoreactivity with...

Multi-chain polypeptide-containing tri-specific binding molecules

Tri-specific binding molecules that specifically bind to multiple c...

Variant CD3-binding domains and their use in combination therapies...

Bi-specific monovalent diabodies that are capable of binding CD19 a...

PD-1-binding molecules and methods of use thereof

B7-H3 directed antibody drug conjugates

Bispecific binding molecules that are capable of binding CD137 and...

Bi-specific monovalent Fc diabodies that are capable of binding CD3...

ADAM9-binding molecules, and methods of use thereof

Combination therapy for the treatment of cancer

Covalently bonded diabodies having immunoreactivity with PD-1 and L...

Combination therapy for the treatment of cancer

LAG-3-binding molecules and methods of use thereof

HER2/neu-specific antibodies and methods of using same

B7-H3 binding molecules, antibody drug conjugates thereof and metho...

Bispecific molecules having immunoreactivity with PD-1 and CTLA-4,...

Bi-specific monovalent diabodies that are capable of binding to gpA...

Bi-specific monovalent diabodies that are capable of binding CD123...

Multi-chain polypeptide-containing tri-specific binding molecules

Multi-chain polypeptide-containing tri-specific binding molecules t...

Bi-specific monovalent diabodies that are capable of binding CD19 a...

PD-1-binding molecules and methods of use thereof

Bi-specific monovalent Fc diabodies that are capable of binding CD3...

Covalently bonded diabodies having immunoreactivity with PD-1 and L...

HER2/neu-specific antibodies and methods of using same

Bi-specific monovalent diabodies that are capable of binding to gpA...

Patents Applicationslast 30 patents

BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND...

MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES T...

LAG-3-Binding Molecules and Methods of Use Thereof

TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE C...

METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...

Variant CD3-Binding Domains and Their Use in Combination Therapies...

Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 a...

PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF

METHODS FOR THE USE OF A PD-1 X CTLA-4 BISPECIFIC MOLECULE

B7-H3 DIRECTED ANTIBODY DRUG CONJUGATES

CD137 BINDING MOLECULES AND USES THEREOF

Therapy for the Treatment of Cancer

BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND...

Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD3...

ADAM9-Binding Molecules, and Methods of Use Thereof

Combination Therapy for the Treatment of Cancer

HER2/neu-Specific Antibodies and Methods of Using Same

Combination Therapy for the Treatment of Cancer

Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and L...

IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF

IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF

LAG-3-Binding Molecules and Methods of Use Thereof

NOVEL B7-H3 BINDING MOLECULES, ANTIBODY DRUG CONJUGATES THEREOF AND...

Variant CD3-Binding Domains and Their Use in Combination Therapies...

METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...

Bi-Specific Monovalent Diabodies That are Capable of Binding CD123...

COMBINATION THERAPY

PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF

Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 a...

MULTI-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES T...